ORIQ

ORIQ is not an operating business — it is a blank-check (SPAC) shell incorporated in the Cayman Islands in September 2024, run from Singapore, that IPO'd 6,000,000 units for $60M gross on July 3, 2025. The MD&A is explicit: 'We have neither engaged in any operations nor generated any revenues to date,' and the entire FY2025 net income of $683K is simply $1,361,271 of interest earned on Treasuries in the Trust Account minus $678,173 of G&A. So the headline 'fundamentals' are artifacts of the IPO mechanics, not performance: total assets jumped to $72.3M (the +26,687% YoY is cash dropping into trust), and the 63% ROE is interest on trust assets sitting against a tiny $1.09M of permanent equity — neither is a sign of business quality. There is no franchise here to value on earnings or revenue.

What you are actually buying at $10.32 is a claim on the trust plus an option on a future business combination. With ~$60M+ in trust against the public shares, the per-share redemption/trust value anchors near $10, so the current price is a modest premium to cash-in-trust. That redemption right is the key feature: a public holder can elect to redeem at the pro-rata trust value, which makes the downside from here fairly contained — you are paying ~3% over what you could in principle redeem for. That is why this is a hold and not a sell or avoid: the balance sheet is clean (liabilities/equity 0.16x, $175K total liabilities, all of it trust-funded), and the structure protects capital better than a typical money-losing micro-cap.